Lipoatrophy revisited

Trends in Endocrinology and Metabolism

Volumn 11, Issue 10, 2000, Pages 410-416

  Reitman, Marc L ^a   Arioglu, Elif ^a   Gavrilova, Oksana ^a   Taylor, Simeon I ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

DIABETES MELLITUS; GENE MUTATION; HUMAN; INSULIN RESISTANCE; LIPOATROPHY; LIPODYSTROPHY; PRIORITY JOURNAL; REVIEW; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS, LIPOATROPHIC; HUMANS; MICE;

EID: 0033664795     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(00)00309-X     Document Type: Review

References (61)

1. The search for human obesity genes
2. Environmental contributions to the obesity epidemic
3. Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy
4. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice
5. Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin
6. Regulating adipogenesis
7. Transcriptional activation of adipogenesis
8. The lipodystrophies and other rare disorders of adipose tissue
9. Generalized lipodystrophy, congenital and acquired (lipoatrophy)
10. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy
11. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy
12. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C
13. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease
14. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy
15. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy
16. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34
17. Genetic exclusion of 14 candidate genes in lipoatropic diabetes using linkage analysis in 10 consanguineous families
18. Partial lipodystrophy associated with juvenile dermatomyositis: Report of two cases
19. The complement abnormalities of lipodystrophy
20. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
21. Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy
22. Inhibition of adipocyte differentiation by HIV protease inhibitors
23. HIV protease inhibitors block human preadipocyte differentiation, but not via the PPARgamma/ RXR heterodimer
24. Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease
25. Lipodystrophy in patients naive to HIV protease inhibitors
26. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in glut4
27. Expression of the mitochondrial uncoupling protein gene from the ap2 gene promoter prevents genetic obesity
28. Transgenic mice overexpressing the beta 1-adrenergic receptor in adipose tissue are resistant to obesity
29. Targeted expression of a toxin gene to adipose tissue: Transgenic mice resistant to obesity
30. Troglitazone action is independent of adipose tissue
31. Life without white fat: A transgenic mouse
32. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: Model for congenital generalized lipodystrophy
33. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
34. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice
35. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
36. Leptin and diabetes in lipoatrophic mice
37. The glucose fatty-acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
38. What if Minkowski had been ageusic? An alternative angle on diabetes
39. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
40. Leptin and the regulation of body weight in mammals
41. Direct antidiabetic effect of leptin through triglyceride depletion of tissues
42. Torpor in mice is induced by both leptin-dependent and -independent mechanisms
43. Efficacy and safety of troglitazone in treatment of lipodystrophy syndromes
44. Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro insulin analog
45. Familial partial lipodystrophy: Two types of an X linked dominant syndrome, lethal in the hemizygous state
46. Insulin-resistant diabetes mellitus and hypermetabolism in mandibuloacral dysplasia: A newly recognized form of partial lipodystrophy
47. Abnormal blood glucose regulation in Cockayne's syndrome
48. Early manifestations of the carbohydrate-deficient glycoprotein syndrome
49. Autosomal dominant partial lipodystrophy associated with Rieger anomaly, short stature, and insulinopenic diabetes
50. Short syndrome and insulin resistance
51. Lipodystrophy and hepatomegaly with diabetes, lipaemia, and other metabolic disturbances: A case throwing new light on the action of insulin
52. Dysregulation of insulin-like growth factors in a case of generalized acquired lipoatrophic diabetes mellitus (Lawrence syndrome) connected with autoantibodies against adipocyte membranes
53. Barraquer-Simons syndrome (with sensorineural deafness): A contribution to the differential diagnosis of lipodystrophy syndromes
54. A case of acquired partial lipodystrophy associated with localized scleroderma and undifferentiated connective tissue disease
55. Juvenile dermatomyositis associated with partial lipoatrophy
56. Partial lipodystrophy and dermatomyositis
57. Partial lipodystrophy and familial c3 deficiency
58. Annular and semicircular lipoatrophies. Report of three cases and review of the literature
59. Mesenteric lipodystrophy
60. Localized skin reactions to insulin: Insulin lipodystrophies and skin reactions to pumped subcutaneous insulin therapy
61. Localized lipoatrophy due to recombinant growth hormone therapy in a child with 6.7 kilobase gene deletion isolated growth hormone deficiency